Current kidney function measurements – estimated GFR and UACR – are meant to diagnose whether kidney disease is present in a given patient and at what stage. Conversely, KidneyIntelX is designed to predict whether or not an adult patient with type 2 diabetes and chronic kidney disease stags 1-3b will progress, possibly resulting in kidney failure.
In fact, KidneyIntelX has a growing body of evidence via validation, utility and economic studies, including a demonstrated 72% improvement in predicting those patients who are at high risk for rapid progressive decline in kidney function vs current standard of care.